Holographic Electron Density Shape Theorem and Its Role in Drug Design and Toxicological Risk Assessment

• Published in: Journal of Chemical Information and Computer Sciences Vol. 39; no. 2; pp. 224 - 230
• Main Author: Mezey, Paul G
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 01.03.1999
• Subjects: Biological activity; Chemical structures; Computerized information storage and retrieval; Drug Design; Holography; Pharmaceutics; Polycyclic Aromatic Hydrocarbons - chemistry; Polycyclic Aromatic Hydrocarbons - toxicity; Risk Assessment; Static Electricity; Toxicology
• ISSN: 0095-2338; 1549-960X
• DOI: 10.1021/ci980072y

Each complete, boundaryless molecular electron density is fully determined by any nonzero volume piece of the electron density cloud. This inherent feature of molecules, called the “holographic” property of molecular electron densities, provides a strong foundation for the local, quantum chemical shape analysis of various functional groups, pharmacophores, and other local molecular moieties. A proof is presented for the relevant molecular shape theorem, the “holographic electron density shape theorem”, and the role of this theorem in quantum chemical, quantitative shape−activity relations (QShAR) is discussed. The quantum chemical methods of molecular shape analysis can be extended to ab initio quality electron densities of macromolecules, such as proteins, as well as to local molecular moieties, such as functional groups or pharmacophores, based on the transferability and additivity of local, fuzzy density fragments and the associated local density matrixes within the framework of the ADMA (Adjustable Density Matrix Assembler) approach. In addition to new results on chemical bonding and the development of macromolecular force methods, the new methodologies are also applicable to QShAR studies in computer-aided drug discovery and in toxicological risk assessment.